8th Microbiome Movement Drug Development Summit

  • June 28, 2023 - June 30, 2023
  • Boston, MA, USA

Biomica’s CEO, Dr. Elran Haber, will participate in a panel at the upcoming 8th Microbiome Movement Drug Development Summit, titled: “Evaluating Current Market Dynamics to Navigate Future Investment Possibilities”.

For more details and registration: https://microbiome-summit.com/

Back to all News

Highlighted News About Biomica

ASCO 2024 logo
Apr 16, 2024

American Society of Clinical Oncology (ASCO) 2024 Annual Meeting

We’re pleased to announce that Dr. Shiri Meshner, our VP of Research and Development, will be participating in the Pharmabiotic Conference 2024. She’ll be presenting alongside Claire Derlot, Chief Business Officer of Biose Industrie, on the topic “Biomica & Biose Industrie: The clinical journey of a multi-strain LBP”. Additionally, Dr. Meshner will contribute to a panel discussion focusing on Clinical Design & Methodology.